ResearcherSamsung Medical CenterNo recent work listed

Soojung Hahn

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6250-1666; OpenAlex author ID A5040154817. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper

Papers 1

Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma. Co-author PMID 37293149 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jae Hyeon Kim · 1 shared paper, 2023 · strength 0.19
- Paper Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma. PMID 37293149 ↗
Sang‐Man Jin · 1 shared paper, 2023 · strength 0.19
- Paper Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma. PMID 37293149 ↗
In Woong Han · 1 shared paper, 2023 · strength 0.19
- Paper Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma. PMID 37293149 ↗
Sang Hyun Shin · 1 shared paper, 2023 · strength 0.19
- Paper Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma. PMID 37293149 ↗
Hye Min Kim · 1 shared paper, 2023 · strength 0.19
- Paper Anti-cancer effects of metformin in a 3D co-culture model of pancreatic ductal adenocarcinoma. PMID 37293149 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.